"UnitedHealth is the leading insurance company in the U.S. and is currently undergoing a tough period due to a series of unforeseen events in the past year. The UnitedHealthcare CEO was assassinated last year, and since then, the whole industry has started 'simplifying' and 'streamlining' insurance claims."
"EBITDA has declined from $36.33 billion in 2023 to $23.06 billion in 2025. This is despite revenue growing from $371.62 billion to $447.57 billion in the same period. Earnings are essentially back to 2019 levels, and so is the stock."
"I don't see an overnight snapback, but I do see significant gains in the next year and a half as margins stabilize and UnitedHealth starts reaping the benefits of the growing revenue."
Value stocks are experiencing a resurgence as investors move away from growth stocks. UnitedHealth Group, Pinterest, and The Trade Desk are currently undervalued. Despite recent challenges, UnitedHealth is expected to recover as margins stabilize and revenue grows. The company has faced management upheaval and a decline in EBITDA, but long-term prospects remain positive. Analysts anticipate significant gains over the next year and a half as the market adjusts to the company's improving fundamentals.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]